NCT05772650 is a clinical trial of e-Health Program in Mental Health Wellness 1, sponsored by McGill University.

Who is sponsoring NCT05772650?

NCT05772650 is sponsored by McGill University.

What drugs are being tested in NCT05772650?

Interventions in NCT05772650: e-Health Program.

What condition does NCT05772650 study?

NCT05772650 studies Mental Health Wellness 1.

Is NCT05772650 still recruiting?

NCT05772650 is currently status unknown. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT05772650

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Online Mood Booster Challenge to Support Physical and Mental Health

Status unknown Last updated 16 March 2023

What this trial tests

trial testing e-Health Program in Mental Health Wellness 1 in 500 participants. Status unknown.

Timeline

6 February 2023

Primary endpoint
16 April 2023

30 June 2023

Quick facts

Lead sponsor	McGill University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	6 February 2023
Primary completion	16 April 2023
Estimated completion	30 June 2023
Sites	1 location across Canada

Drugs / interventions tested

e-Health Program

Conditions studied

Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →

Sponsor

McGill University

Who can join

Eligibility, any sex, with Mental Health Wellness 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Healthier Together Mood Booster Challenge - To improve mental and physical fitness, while providing participants with online education, tracking, social connectivity, and feedback.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mental Health Wellness 1

Currently open trials in the same condition.

NCT07128095 — COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise · recruiting
NCT06254924 — Qoyangnuptu: Qoyangnuptu Intervention (QI) App · NA · recruiting
NCT06254872 — Qoyangnuptu: Peer Mentor · NA · recruiting
NCT05865782 — Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes · NA · recruiting
NCT05825040 — Randomized Controlled Trial on Precision Mental Health · NA · recruiting

Other McGill University trials

Trials by the same sponsor.

NCT07178535 — Feasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke · NA · not yet recruiting
NCT07445841 — Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training · NA · recruiting
NCT07447830 — The Pain Reduction Using Immersive Virtual Reality During Wound Care Evaluation Study at Maimonides (PRISM) - Pilot Stud · NA · recruiting
NCT07497425 — Neuroimmune Responses to Exercise in Chronic Back Pain · NA · recruiting
NCT06994559 — Music as an Adjunct to Ketamine Therapy for Chronic Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05772650 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McGill University
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05772650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing